Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 69, No 7 (2020)

Articles

Stake on transfer: evolution of a regulatory framework for the development of the pharmaceutical industry

Rudko A.I., Konikov D.L., Sidorov K.O., Ilyinova J.G.

Abstract

Drug technology transfer is one of the ways to provide the country's population with affordable and effective drugs. The development of the pharmaceutical industry and government initiatives aimed at modernizing healthcare make Russia attractive to international pharmaceutical business, which in turn allows the Russian pharmaceutical industry to obtain modern world-class technologies and equipment, high-tech jobs, and production management methods and enables partners to have a guaranteed sales market. However, despite the importance and priority of drug technology transfer, foreign manufacturers face a variety of economic and legal problems when making strategic decisions on technology transfer. The development of high-tech production of medicines is associated with the technology transfer process. The above process arises from the transition from one stage of the drug life cycle to the next one. The important feature characterizing the transfer process is the regulation of the transfer of knowledge and technologies, which should ensure the stable safety of a drug and its efficacy, and the reproducibility of quality control methods, by taking into account the results of industrial production. The above aspects of drug circulation are laid down at the stage of development. The specificity of the pharmaceutical industry lies in the need to develop technologies in the context of market globalization and intense competition in drug development, production, and sales. In this connection, the export opportunities of states come to the fore, the important part of which is the convenience of registering and launching modern, effective, safe and competitive drugs in terms of price on the international market.
Farmaciya (Pharmacy). 2020;69(7):5-9
pages 5-9 views

Determination of genotoxic impurities in pharmaceutical substances

Ananyina O.V., Khorolsky M.D., Ramenskaya G.V., Zhukov E.A., Maslennikova N.V.

Abstract

The paper considers the approaches applied to determine impurities having potential genotoxicity in the pharmaceutical substances. This type of impurities is able to disrupt the structure of DNA, regardless of their concentration entering the body, as well as to tend to accumulate in tissues and organs. In view of the fact that the cases of detecting genotoxic impurities in pharmaceutical substances have become frequent, the literature sources describing the determination of the impurities in various matrices have been studied. The results of the investigation could divide the genotoxic impurities into two groups, based on their origin. The most commonly used methods for their identification have been defined for each group. Trends in the determination of genotoxic impurities as an aspect of quality control have been formulated.
Farmaciya (Pharmacy). 2020;69(7):10-16
pages 10-16 views

Photometric determination of succinic acid in liquid preparations

Shormanov V.K., Shvets O.M., Belikova M.A., Tarasova O.V.

Abstract

Introduction. Succinic acid is a substance having various types of biological activity and is part of many combination preparations used in medical and veterinary practice. Objective: to develop a procedure for the determination of succinic acid that would be distinguished by selectivity, sufficient sensitivity, and simplicity of instrumentation. Material and methods. The investigation objects were succinic acid, a cytoflavin solution for injections, and Dorogov's antiseptic stimulator 2 (DAS-2)-based solution. Photometry in the visible region of the spectrum based on the conversion of the analyte into stained dihydronaphthazarin is considered as an analysis method. Results. The investigators proposed a modified version of obtaining 5,8-dioxy-2,3-dihydro-1,4-naphthaquinone (dihydronaphthazarin) (a stained analytical form) from succinic acid through its treatment with excess hydroquinone and concentrated (p=1.830-1.832 g/cm3) sulfuric acid for 30 minutes sequentially at temperatures of 105-110 and 145°С. The stained product is able to be extracted with toluene. The spectrum of the product in the toluene medium is characterized by the presence of a vibrational band with a maximum at 520 nm. The considered chromogenic reaction in the proposed modification proceeds quantitatively. The linear relationship between the reference succinic acid concentration in the photometric solution and the optical density corresponds to the range of 25-250 |ig/ml. Conclusion. Procedures were developed for the photometric determination of succinic acid in the cytoflavin solution for injection and in DAS-2-based solution. The validation characteristics of the procedure showed the agreement of their criteria for linearity, selectivity, correctness, and precision.
Farmaciya (Pharmacy). 2020;69(7):17-22
pages 17-22 views

Elaboration of approaches to standardizing walnut (Juglans regia) leaves

Zimenkina N.I., Kurkin V.A.

Abstract

Introduction. Medicinal plant raw materials of representatives of the genus Juglans of walnuts have antimicrobial and general tonic effects due to the fact that it contains naphthoquinone derivatives (juglone, hydrojuglone) and other phenolic compounds. Despite a wide spectrum of pharmacological activities, walnut (Juglans regia L.) is not pharmacopoeial in the Russian Federation. For inclusion of walnut leaves into the State Pharmacopoeia of the Russian Federation, it is necessary to conduct a set of pharmacognostic studies, including the development of regulatory documents that confirm the quality of medicinal plant materials. Objective: to develop a procedure for the quantitative determination of total flavonoid contents in walnut leaves. Material and methods. The investigation used the walnut leaves stored in the Samara State Medical University Botanical Garden in 2018-2019, as well as differential spectrophotometry. Results. A study of spectral characteristics showed that the total content of flavonoids in the walnut leaves could be determined with reference to rutin at an analytical wavelength of 412 nm. A procedure for quantification of the amount of flavonoids in the investigated plant raw materials was developed and validated. The error of a single determination with a confidence level of 95% is ±3.49%. Conclusion. The developed procedure was used to analyze a number of samples of walnut leaves growing in the Samara State Medical University Botanical Garden. The total flavonoid contents calculated with reference to rutin ranged from 3.58 to 3.72%. The developed procedure can be used in further investigations of this type of medicinal plant material.
Farmaciya (Pharmacy). 2020;69(7):23-28
pages 23-28 views

Design and analysis of a liposomal melatonin formulation for intravenous administration

Ageev V.P., Kulikov O.A., Gurevich K.G., Shlyapkina V.I., Zaborovsky A.V.

Abstract

Introduction. Cerebrovascular accident is one of the major causes of death worldwide. This group of diseases frequently leads to incapacity, disability, and a poor quality of life and requires long-term treatment and rehabilitation. The use of antioxidants that include melatonin among others is a promising treatment for cerebral circulatory disorders. In view of the proven efficacy of melatonin for these disorders, it is rational to design its parenteral formulation for accelerated drug delivery to the patient's body, especially in the situations where this drug cannot be administered orally. The liposomal formulation of melatonin allows its intravenous injection and is likely to promote its passage through the blood-brain barrier. Objective: to develop a procedure to prepare a liposomal melatonin formulation for parenteral administration and to investigate the resulting dosage form. Material and methods. Liposomes were obtained by hydration of the lipid film prepared from phospholipids and cholesterol, by using a rotary evaporator. Melatonin was incorporated into the lipid membrane, after dissolving the agent in chloroform. The size of liposomes was measured by dynamic light scattering. The liposomes were purified from unincorporated melatonin by dialysis through a semipermeable membrane. The efficiency of melatonin incorporation into the liposomes was determined using UV spectrophotometry. Results. A liposomal melatonin formulation with a particle size of 66.6±10-nm was obtained. The drug concentration in this preparation was 1.8±0.01 mg/ml. The efficiency of incorporating melatonin into liposomes was 87.8±0.5%. The ratio of the incorporated melatonin to phospholipids was 0.035. Conclusion. The obtained liposomes with melatonin can be suitable for intravenous administration, and, if they can penetrate the blood-brain barrier, provide the targeted delivery of high-concentration melatonin to the central nervous system, where melatonin will exert its therapeutic effect.
Farmaciya (Pharmacy). 2020;69(7):29-33
pages 29-33 views

Optimization of the composition of the anti-inflammatory drug Piron

Suldin A.S., Puchnina S.V., Suldin A.V.

Abstract

Introduction. The original Russian pharmaceutical substance Piron belongs to the group of nonsteroidal anti-inflammatory drugs. Its dosage form (50-mg tablets) has been designed for the treatment of musculoskeletal system diseases. Objective: to optimize the composition of 50-mg film-coated Piron tablets in order to increase the release of the pharmaceutical substance from the tablets into the dissolution medium. Material and methods. The composition of the tablets was optimized by incorporating the disintegrants of various chemical compositions. The release of the active ingredient was assessed in accordance with the requirements of the 14th Edition of the State Pharmacopoeia of the Russian Federation. The dissolution test was carried out on an RC-3 paddle mixer. Quantitative determination was performed using an HPLC system based on a Shimadzu modular chromatograph (Japan). Results. A number of compositions for direct compression were designed and tested, where disintegrants (crospovidone, croscarmellose sodium, and pregelatinized starch) and silicon dioxide (Aerosil) were additionally incorporated in various combinations. The degree of transition of the active substance into the solution was quantified by HPLC and a relationship was determined between the release of Piron into the dissolution medium and the proportion of various disintegrants in the composition of tablets. The optimal composition of the solid dosage form was established and a pilot batch of tablet cores was obtained using a ZP-9 rotary tablet press. The quantity of the active ingredient passing from the tablets of this composition into the solution was found to be 98%. Conclusion. The investigators have designed the optimized composition of 50-mg film-coated Piron tablets with the increased release of the active ingredient, which contains a combination of two disintegrants: croscarmellose sodium and pregelatinized starch. The chosen excipients considerably improve the release of the substance from the dosage form as compared to the baseline values.
Farmaciya (Pharmacy). 2020;69(7):34-39
pages 34-39 views

Problems of biological therapy for rheumatic diseases

Shakirova D.K., Ugoltsova V.N., Abdulganieva D.I., Safiullin R.S., Yarkaeva F.F.

Abstract

Introduction. Rheumatic diseases are one of the most common pathologies in the world, occupying a leading position in primary disability and chronicity among the group of musculoskeletal system diseases in both Russia and worldwide. The important problem is patients' resistance to standard disease-modifying therapy, which requires biological therapy to achieve remission of the disease. With an increase in epidemiological indicators, there is an acute problem of the availability of expensive high-tech therapy with biological agents. Objective: to analyze the drug supply system for patients with rheumatic diseases at the federal and regional levels. Material and methods. The investigation materials were the legal framework regulating drug provision for patients with rheumatic diseases; statistical data of the Ministries of Health of the Russian Federation and the Republic of Tatarstan; and guidelines for the treatment of these diseases. Content analysis methods and documentary research and statistical studies were used. Results. The list of drugs sold on preferential terms for the treatment of patients with rheumatic diseases was made. In many cases, disease-modifying therapy cannot control disease progression. In this case, the disease-modifying therapy is substituted for expensive treatment with biological agents. Gene therapy is indicated for 15% of patients with these diseases; however, the high cost makes this therapy unaffordable for everyone in need. Conclusion. There is a problem of the availability of gene therapy in the treatment of rheumatic diseases due to the stable growth of the need for expensive drugs in the context of a budget deficit. It is necessary to modernize the system for providing rheumatic disease patients with biological agents and to elaborate methodological approaches to providing these drugs at the regional level.
Farmaciya (Pharmacy). 2020;69(7):40-45
pages 40-45 views

Study of the dislocation of pharmacy organizations in case of the city of Kazan

Safiullin R.S., Muslimova N.N., Gribova Y.V., Garifullina G.K.

Abstract

Introduction. The importance of pharmacies has not been diminishing for about 400 years. In modern conditions, retail and wholesale pharmaceutical organizations provide medicinal assistance to the population and health care facilities. The transition of pharmaceutical organizations to market relations has made changes in the structure of pharmaceutical service at all levels, various organizational and legal entities of pharmaceutical (pharmacy) organizations have appeared, and their management system and principles of placement have changed. Objective: to investigate the organizational aspects of pharmacy dislocations (in case of one Kazan district). Material and methods. The investigation object was the pharmacies of the Novo-Savinovsky District of Kazan. The study methods were sociological (questionnaire survey of pharmacy managers and visitors) and cartographic analyses. Results. The investigators analyzed the responses from two groups of respondents (pharmacy managers and visitors) concerning the most important issues in planning the dislocation of pharmacies in the region: the average radius of pharmacy service; the average time taken to move from pharmacy to pharmacy; the average number of visitors per pharmacy per day, and a number of other issues. Conclusion. The study showed the need to develop standards for the dislocation of pharmacies. Investigation of the organizational aspects of the dislocation of pharmacies in case of one of the most numerous and dynamically developing Kazan districts made it possible to propose standards for the placement of pharmacies, by taking into account the optimal size of the population served by a pharmacy, the number of pharmacy visitors during 1 day and the time required to move from pharmacy to pharmacy.
Farmaciya (Pharmacy). 2020;69(7):46-50
pages 46-50 views

Investigation of the subacute toxicity (cumulation) of the liquid extract Phytoallergoderm

Imamaliev B.A., Fayzieva Z.T.

Abstract

Introduction. Atopic dermatitis leads to the development of allergic inflammation that has age-related characteristics of the location and morphology of inflammatory foci, as well as painful itchy skin. The Tashkent Pharmaceutical Institute has developed the liquid extract Phytoallergoderm for the topical therapy of this disease. Studying the cumulation of the drug assists in determining its damaging effect during repeated injections and in establishing the optimal course of safe medication administration in an inpatient setting. Objective: to investigate the subacute toxicity (cumulation) of the liquid extract Phytoallergoderm. Material and methods. Forty outbred albino mice divided into 2 gender groups were used to investigate the subacute toxicity of the liquid extract, by using the method proposed by R.K. Lim. Before starting the experiment, the liquid extract was dealkylated to eliminate the nonspecific activity of ethyl alcohol that was part of the agent. Results. During the entire (24-day) experiment after dermal application of the liquid extract Phytoallergoderm, there were no statistically significant weight changes in the experimental animals versus the intact group. During the entire experiment, no deaths of animals were recorded either. The drug was well tolerated during repeated dermal applications. The calculated cumulation coefficient had a value of more than 1, which indicates drug addiction. Conclusion. The liquid extract Phytoallergoderm had practically no cumulative effect when applied to the skin and is well tolerated. The test drug was found to have a potential sedative effect and neurotropic activity.
Farmaciya (Pharmacy). 2020;69(7):51-56
pages 51-56 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies